文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

严重急性呼吸综合征冠状病毒2德尔塔和奥密克戎变异株优势流行期间成人COVID-19相关住院率:按种族/民族和疫苗接种状态分析——COVID-NET,14个州,2021年7月至2022年1月

COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-03-25

分析COVID-NET 14个州数据,比较德尔塔(2021年7月1日至12月18日)和奥密克戎(2021年12月19日至2022年1月31日)优势流行期间≥18岁成人COVID-19相关住院率。奥密克戎期间每周住院率峰值达38.4/10万成人,高于德尔塔期间的15.5;所有疫苗接种状态成人住院率均上升。2022年1月未接种成人住院率是接种加强针或额外剂次成人的12倍,是仅接种基础系列成人的4倍;仅接种基础系列成人是接种加强针或额外剂次成人的3倍。奥密克戎期间非西班牙裔黑人成人峰值住院率约为非西班牙裔白人成人的近4倍,为疫情期间各种族和民族组中最高。

要点

  • 奥密克戎优势流行期间每周COVID-19相关住院率峰值达38.4/10万成人,德尔塔期间为15.5。
  • 所有成人无论疫苗接种状态住院率均上升;未接种者住院率最高。
  • 2022年1月未接种成人住院率是接种加强针或额外剂次成人的12倍。

核心结论

  • 所有成人应保持COVID-19疫苗接种最新状态以降低COVID-19相关住院风险。
  • 实施策略促进公平接种COVID-19疫苗,包括建立疫苗信心、提高对疫苗益处的认识和消除接种障碍,对于COVID-19住院率不成比例偏高的人群(包括黑人成人)是紧迫的公共卫生优先事项。

研究设计与样本

  • 分析COVID-19相关住院监测网络(COVID-NET)14个州的数据,比较≥18岁成人在德尔塔(2021年7月1日至12月18日)和奥密克戎(2021年12月19日至2022年1月31日)优势流行期间的COVID-19相关住院率,总体及按种族/民族和疫苗接种状态分层。

主要发现

  • 奥密克戎优势流行期间每周COVID-19相关住院率峰值为38.4/10万成人,德尔塔优势流行期间为15.5。
  • 所有成人无论疫苗接种状态(未接种、仅基础系列、基础系列加加强针或额外剂次)住院率均上升。
  • 2022年1月奥密克戎传播高峰期间,未接种成人住院率是接种加强针或额外剂次成人的12倍,是仅接种基础系列成人的4倍。
  • 仅接种基础系列但未接种加强针或额外剂次的成人住院率是接种加强针或额外剂次成人的3倍。
  • 奥密克戎优势流行期间,非西班牙裔黑人成人峰值住院率约为非西班牙裔白人成人的近4倍,为疫情期间任何种族和民族组中观察到的最高率;与德尔塔优势流行期间相比,奥密克戎优势流行期间未接种的黑人住院成人比例增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Beginning the week of December 19-25, 2021, the B.1.1.529 (Omicron) variant of SARS-CoV-2 (the virus that causes COVID-19) became the predominant circulating variant in the United States (i.e., accounted for >50% of sequenced isolates).* Information on the impact that booster or additional doses of COVID-19 vaccines have on preventing hospitalizations during Omicron predominance is limited. Data from the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET)† were analyzed to compare COVID-19-associated hospitalization rates among adults aged ≥18 years during B.1.617.2 (Delta; July 1-December 18, 2021) and Omicron (December 19, 2021-January 31, 2022) variant predominance, overall and by race/ethnicity and vaccination status. During the Omicron-predominant period, weekly COVID-19-associated hospitalization rates (hospitalizations per 100,000 adults) peaked at 38.4, compared with 15.5 during Delta predominance. Hospitalizations rates increased among all adults irrespective of vaccination status (unvaccinated, primary series only, or primary series plus a booster or additional dose). Hospitalization rates during peak Omicron circulation (January 2022) among unvaccinated adults remained 12 times the rates among vaccinated adults who received booster or additional doses and four times the rates among adults who received a primary series, but no booster or additional dose. The rate among adults who received a primary series, but no booster or additional dose, was three times the rate among adults who received a booster or additional dose. During the Omicron-predominant period, peak hospitalization rates among non-Hispanic Black (Black) adults were nearly four times the rate of non-Hispanic White (White) adults and was the highest rate observed among any racial and ethnic group during the pandemic. Compared with the Delta-predominant period, the proportion of unvaccinated hospitalized Black adults increased during the Omicron-predominant period. All adults should stay up to date (1) with COVID-19 vaccination to reduce their risk for COVID-19-associated hospitalization. Implementing strategies that result in the equitable receipt of COVID-19 vaccinations, through building vaccine confidence, raising awareness of the benefits of vaccination, and removing barriers to vaccination access among persons with disproportionately higher hospitalizations rates from COVID-19, including Black adults, is an urgent public health priority.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Taylor CA, Whitaker M, Anglin O, et al. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35324880. doi:10.15585/mmwr.mm7112e2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。